Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Norvēģija -
norvēģu -
Statens legemiddelverk
pirfenidone sandoz 801 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
pirfenidone sandoz 267 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaksiner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Norvēģija -
norvēģu -
Statens legemiddelverk
pirfenidone newbury 267 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 267 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
pirfenidone newbury 801 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 801 mg
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
instanyl
takeda pharma a/s - fentanyl citrate - pain; cancer - analgetika - instanyl er indisert for behandling av gjennombrudd smerte hos voksne allerede mottar vedlikehold opioid terapi for kronisk kreft smerter. gjennombruddssmerter er en forbigående forverring av smerte som oppstår på bakgrunn av ellers kontrollert vedvarende smerte. patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.
Norvēģija -
norvēģu -
Statens legemiddelverk
cetirizin bluefish 10 mg
bluefish pharmaceuticals ab - cetirizindihydroklorid - tablett, filmdrasjert - 10 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
malarone 250 mg / 100 mg
glaxosmithkline as - atovakvon / proguanilhydroklorid - tablett, filmdrasjert - 250 mg / 100 mg